Mechanisms of itch evoked by β-alanine.
Level 5 - mechanism / opinion, no new human data
Preclinical animal mechanism research with experimental human intradermal challenge
PubMed 23077038 · doi:10.1523/JNEUROSCI.3509-12.2012
What was done
Researchers investigated the molecular and cellular mechanisms of β-alanine-induced itch using mouse models and an experimental human challenge. In mice, they evaluated itch-associated behaviors, the requirement of the G-protein-coupled receptor MrgprD, and the responses of primary sensory neurons to β-alanine, heat, noxious mechanical stimuli, and histamine. In humans, β-alanine was administered intradermally to observe itch, wheal, and flare responses.
What was found
In mice, β-alanine elicited itch behavior requiring MrgprD-expressing primary sensory neurons. These neurons innervated skin and responded to β-alanine, heat, and mechanical noxious stimuli, but not histamine. In humans, intradermal β-alanine induced itch without wheal or flare. The abstract reported no numerical values or sample sizes.
Why it matters
This study identifies the MrgprD receptor and a histamine-independent neural circuit as the pathway for β-alanine-induced paresthesia and itch. These findings reveal a potential target for treating clinical itch conditions unresponsive to antihistamines.
Limits
The abstract provides no sample sizes, dosages, or quantitative outcome measures. Findings rely predominantly on animal models, and the human component used intradermal injection rather than oral ingestion typical of supplement use.
Cited by
- supports The paresthesia/tingling caused by beta-alanine is mediated by sensory receptor activation rather than a histamine dump.